Study evaluates frailty tools predicting survival and infection risk in myeloma patients, suggesting distinct implications for care.
Both MRP and FI are effective frailty assessment tools in NDMM patients. They significantly correlate with OS, PFS.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: